湿性年龄相关性黄斑变性中西医药物治疗的研究进展OA
Advances in the Pharmacological Treatment of Wet Age-related Macular Degenera-tion:A Comparative Study of Traditional Chinese Medicine and Western Medicine
年龄相关性黄斑变性(AMD)是导致中老年人视力损伤的常见眼病,致盲率高,已成为我国防盲治盲的重点眼病之一.随着研究的不断深入,湿性AMD的中西医药物治疗均取得显著进展.本文通过梳理国内外相关文献,对湿性AMD的中西医药物治疗进展进行综述,发现西医治疗药物主要包括抗血管内皮生长因子及其他细胞因子药物、双特异性抗体、生物类似药、基因疗法及长效药物递送系统等,但仍普遍存在治疗周期长、费用高昂、复发率高及部分患者治疗无应答等问题.中医药治疗本病多从肝、肾、脾三脏论治,强调病证结合与辨证施治,但目前仍缺乏大样本、多中心的随机对照试验来提供有力的证据支持.与单一药物治疗相比,中西医结合疗法在临床上显示出更好的疗效,在提高患者最佳矫正视力、减少玻璃体腔注药次数、延缓疾病进展、降低治疗成本等方面具有潜在优势,有望为湿性AMD的临床治疗提供新思路与更多选择.
Age-related macular degeneration(AMD)is a prevalent ocular disease leading to visual impairment in the elderly,with a high rate of blindness.It has become one of the key focus areas for blindness prevention and treatment in our country.With ongoing research,significant ad-vancements have been made in the pharmacological treatments of wet AMD within both Tradi-tional Chinese Medicine(TCM)and Western Medicine(WM).This paper provides a review of the progress in pharmacological therapies for wet AMD by summarizing relevant literature,both do-mestic and international.It was found that Western pharmacological treatments primarily include anti-vascular endothelial growth factor and other cytokine agents,bispecific antibodies,biosimi-lars,gene therapy,and long-acting medicine delivery systems.However,these treatments continue to face challenges such as lengthy treatment durations,high costs,elevated rates of recurrence,and the lack of response in certain patients.TCM approaches to treating this condition largely fo-cus on the harmonious balance among liver,kidney,and spleen,highlighting the importance of syndromic differentiation and tailored therapies.Despite this,there remains a scarcity of large-sample,multi-center randomized controlled trials to provide robust evidence.Compared to mono-therapy,integrative treatment combining TCM and WM has demonstrated superior clinical effi-cacy,showing potential advantages in enhancing patients'best-corrected visual acuity,reducing the frequency of intravitreal injections,delaying disease progression,and lowering treatment costs.This integrative approach may offer new insights and additional options for the clinical treatment of wet AMD.
方露露;黎红梅;张昭;王继芳;梁凤鸣
天津中医药大学第一附属医院,国家中医针灸临床医学研究中心,天津 300381天津中医药大学第一附属医院,国家中医针灸临床医学研究中心,天津 300381天津中医药大学第一附属医院,国家中医针灸临床医学研究中心,天津 300381天津中医药大学第一附属医院,国家中医针灸临床医学研究中心,天津 300381天津中医药大学第一附属医院,国家中医针灸临床医学研究中心,天津 300381
医药卫生
湿性年龄相关性黄斑变性中西医结合药物治疗
wet age-related macu-lar degenerationintegrative medicinepharmacological treatment
《中国中医眼科杂志》 2026 (9)
885-890,6
国家自然科学基金项目(8217442)
评论